Identifying the right sensors in support of hybrid or virtual trials is only the beginning. The ability to distill meaningful clinical insights from massive amounts of data requires a dynamic approach to data ingestion and analysis that will ultimately have the desired impact on the development of new digital endpoints. Join Medidata’s Ben Schlatka, VP of Digital Biomarker Solutions, as he discusses key considerations for developing a comprehensive data strategy to support the creation of new digital endpoints that impact safety monitoring, disease progression, and more effective treatments.
Speaker
Ben Schlatka
VP, Digital Biomarker Solutions, Medidata
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Medidata: Developing a unified approach to support the creation of new digital endpoints
Download and watch the webinar
